(Total Views: 535)
Posted On: 07/12/2021 9:55:47 AM
Post# of 145883
$CYDY News Article - CytoDyn's Trial for Metastatic Triple-Negative Breast Cancer Demonstrates Safety with 350 mg, 525 mg and 700 mg Dosages; Officially Advances to Phase 2 from Phase 1b https://marketwirenews.com/news-releases/cyto...09508.html
(0)
(0)
My Twitter: WhyteStocks